卡倍億(300863.SZ):董事蔣振華買賣可轉債構成短線交易
格隆匯3月24日丨卡倍億(300863.SZ)公佈,公司董事蔣振華於2022年3月22日賣出持有的公司可轉債“卡倍轉債”100張,該交易構成短線交易行為。蔣振華該次短線交易行為產生的收益為6987.45元,其已將獲利金額全數上交公司。
根據《關於可轉換公司債券適用短線交易相關規定的通知》的規定,可轉債屬於《證券法》規定的其他具有股權性質的證券,無論是否進入轉股期,均適用短線交易的相關規定。蔣振華於2022年1月5日通過原股東優先配售方式買入公司可轉債3221張,蔣振華將其所持公司可轉債在6個月內賣出的行為構成短線交易。截止目前,蔣振華未發生任何其他違規行為。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.